NBE-002 / Sotio, Boehringer Ingelheim 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NBE-002 / Sotio, Boehringer Ingelheim
NBE-002-01, NCT04441099: NBE-002 in Patients With Advanced Solid Tumors

Terminated
1/2
12
US
NBE-002
NBE-Therapeutics AG, Cmed Clinical Services
Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer
08/23
08/23

Download Options